Pulmonary rehabilitation in underground salt chambers for people with COPD
Official title: The Impact of Pulmonary Rehabilitation Conducted in Therapeutic Salt Chambers on the Clinical Status of Patients With Chronic Obstructive Pulmonary Disease (COPD)
Run by University School of Physical Education, Krakow, Poland · NCT07122544 · Data updated 2026-11-12
This program will try pulmonary rehabilitation sessions inside underground salt chambers to see if people with COPD breathe better, feel less symptomatic, and improve their fitness.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | University School of Physical Education, Krakow, Poland Academic / other |
| Locations | 1 site (Krakow, Małopolska) |
| Status | Recruiting |
| Started | September 1, 2025 |
| Main results expected | January 1, 2027 |
| Study ends | January 1, 2028 |
| Registry record updated | November 26, 2025 |
| Trial ID | NCT07122544 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
People with stable COPD who meet GOLD-based spirometric criteria (FEV1/FVC < 0.7, FEV1 ≥ 30% predicted), have a negative bronchodilator reversibility test, can participate in exercise, and can give informed consent would be appropriate candidates.
✕Probably not a fit
Patients with recent COPD exacerbation, respiratory failure or other major cardiac, neurologic, oncologic, or musculoskeletal contraindications (including implanted defibrillators or uncontrolled arrhythmias) are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional program offers pulmonary rehabilitation and climatic (microclimate) therapy conducted in subterranean salt chambers characterized by cool, humid, highly ionized air. Participants take part in guided breathing exercises, general fitness training, relaxation sessions, and health education while clinical status and functional outcomes are measured before and after the intervention. Eligible participants must have COPD with post-bronchodilator FEV1/FVC < 0.7 and FEV1 ≥ 30% predicted and be able to perform the exercise program. The intervention is delivered at AKF Kraków in Krakow, Poland, using the underground salt-mine environment as an adjunct to standard rehabilitation techniques.
Why it matters
Potential benefit: If successful, this approach could reduce respiratory symptoms and improve exercise tolerance and quality of life for people with COPD.
How similar studies have gone: Small trials and observational reports of speleotherapy and subterranean microclimate therapies have suggested symptomatic or functional benefits for some respiratory conditions, but high-quality randomized evidence is limited and results are inconsistent.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * COPD diagnosis confirmed by a pulmonology specialist according to the 2025 GOLD guidelines. * FEV1 ≥ 30% of the predicted value. * FEV1/FVC \< 0.7 after bronchodilator administration in spirometry. * Negative bronchodilator reversibility test. * Voluntary written consent to participate in the study. Exclusion Criteria: * COPD exacerbation. * Active cancer or a history of cancer within the past five years. * Musculoskeletal disorders preventing independent movement and participation in exercise tests and training included in the study protocol. * Recent (within six months) surgical procedure or trauma to the chest, abdomen, skull, brain, or eye area. * Severe valvular heart disease. * Implanted cardioverter-defibrillator. * Diagnosed arrhythmias posing a risk of loss of consciousness. * Acute coronary artery disease. * Epilepsy. * Uncontrolled arterial hypertension despite medication. * Primary or secondary immunodeficiencies. * Respiratory failure requiring chronic or intermittent oxygen therapy. * Infectious diseases with fever during the experiment or within two weeks before the study. * Claustrophobia. * Pregnancy. * Simultaneous participation in another rehabilitation program. * Significant changes in pharmacological treatment during the study.
Where it's running
-
AKF Kraków
Krakow, Małopolska, Poland Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Enhanced COPD care for people being checked for lung cancer
This project will test whether finding and treating COPD early in people being checked for possible lung cancer helps symptoms, lung function, and overall care.
-
High-Flow Nasal Cannula vs Noninvasive Ventilation in COPD with Hypercapnia
This study tests whether a high-flow nasal cannula can better support gas exchange and comfort compared with noninvasive ventilation in COPD patients with mild-to-moderate elevated CO2.
-
Risk-based lung cancer screening in COPD patients using ML and clinical models
This study tests whether a PLCOm2012 risk model plus a machine learning model can spot COPD patients at high risk for lung cancer to see if they benefit from low-dose CT screening.
-
Biologics for Type 2 Inflammation in Asthma and COPD in Real World
This real-world study tests whether six biologic drugs can reduce flare-ups and improve symptoms in adults with asthma or COPD treated in routine care in China.
-
Nebulized vs handheld maintenance therapy for COPD patients with limited benefit from inhalers
This trial tests whether switching to a breath-enhanced nebulizer with similar COPD meds helps people who don’t get enough relief from their current handheld inhalers.
-
New breathing tests to diagnose airway disease in hospital and community settings
This study tests whether newer breathing tests can correctly diagnose COPD and airway disease as well as standard spirometry, using tests like capnography and oscillometry in hospital and community settings.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.